Dr Rajagopal Karuppusamy has completed his PhD from University of Delhi, New Delhi, India. He is having 5 years of teaching/academic experience and more than 14 years of experience in generic drug product development. Currently Serving in Pharmaceutical generic company at USA as a Director and Head of Analytical R&D and involved in developing generic products especially for treating ADHD, for pain management, etc Successfully contributed majorly for the developed the generic version of Tamiflu capsules and powder for oral suspension, got first FDA approval for Tamiflu generics. He has published about 25 research papers and having citations of about 250. He has contributed for developing few USP monographs.

Quality by Design, HPLC, GC method development and method validation, Dissolution method development using USP I, II, III, IV, V and VII equipment's for immediate, extended, delayed release capsules/tablets, solid state characterization, Elemental impurities in pharmaceutical and cosmeceuticals, Developing natural medicines to treat diabetes, psoriasis etc,